XML 16 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Paid-in capital
Accumulated deficit
Accumulated other comprehensive  loss
Beginning Balance (in shares) at Dec. 31, 2024   22,156,000      
Balance at beginning of year at Dec. 31, 2024 $ 229,923 $ 222 $ 280,566 $ (32,550) $ (18,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (4,201)     (4,201)  
Other comprehensive income (loss), net of taxes 292       292
Net issuance of restricted shares granted to employees and directors (in shares)   338,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,063   1,063    
Shares effectively repurchased for required employee withholding taxes (in shares)   (80,000)      
Shares effectively repurchased for required employee withholding taxes (416) $ (1) (415)    
Dividends [1] (985)     (985)  
Ending Balance (in shares) at Mar. 31, 2025   22,414,000      
Balance at end of year at Mar. 31, 2025 225,676 $ 224 281,211 (37,736) (18,023)
Beginning Balance (in shares) at Dec. 31, 2024   22,156,000      
Balance at beginning of year at Dec. 31, 2024 229,923 $ 222 280,566 (32,550) (18,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (43,900)        
Other comprehensive income (loss), net of taxes 30        
Ending Balance (in shares) at Jun. 30, 2025   22,657,000      
Balance at end of year at Jun. 30, 2025 185,768 $ 227 282,252 (78,426) (18,285)
Beginning Balance (in shares) at Mar. 31, 2025   22,414,000      
Balance at beginning of year at Mar. 31, 2025 225,676 $ 224 281,211 (37,736) (18,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (39,699)     (39,699)  
Other comprehensive income (loss), net of taxes (262)       (262)
Net issuance of restricted shares granted to employees and directors (in shares)   243,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,044   1,044    
Dividends [1] (991)     (991)  
Ending Balance (in shares) at Jun. 30, 2025   22,657,000      
Balance at end of year at Jun. 30, 2025 185,768 $ 227 282,252 (78,426) (18,285)
Beginning Balance (in shares) at Dec. 31, 2025   22,654,000      
Balance at beginning of year at Dec. 31, 2025 202,277 $ 227 283,449 (63,354) (18,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (4,772)     (4,772)  
Other comprehensive income (loss), net of taxes 139       139
Net issuance of restricted shares granted to employees and directors (in shares)   259,000      
Net issuance of restricted shares granted to employees and directors 0 $ 3 (3)    
Stock compensation expense 1,041   1,041    
Shares effectively repurchased for required employee withholding taxes (in shares)   (58,000)      
Shares effectively repurchased for required employee withholding taxes (183) $ (1) (182)    
Dividends [1] (1,006)     (1,006)  
Ending Balance (in shares) at Mar. 31, 2026   22,855,000      
Balance at end of year at Mar. 31, 2026 197,496 $ 229 284,305 (69,132) (17,906)
Beginning Balance (in shares) at Dec. 31, 2025   22,654,000      
Balance at beginning of year at Dec. 31, 2025 202,277 $ 227 283,449 (63,354) (18,045)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 14,837        
Other comprehensive income (loss), net of taxes $ 254        
Net exercise of stock options (in shares) 49,375        
Ending Balance (in shares) at Jun. 30, 2026   22,989,000      
Balance at end of year at Jun. 30, 2026 $ 217,477 $ 230 285,571 (50,533) (17,791)
Beginning Balance (in shares) at Mar. 31, 2026   22,855,000      
Balance at beginning of year at Mar. 31, 2026 197,496 $ 229 284,305 (69,132) (17,906)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 19,609     19,609  
Other comprehensive income (loss), net of taxes 115       115
Net issuance of restricted shares granted to employees and directors (in shares)   85,000      
Net issuance of restricted shares granted to employees and directors 0 $ 1 (1)    
Stock compensation expense 973   973    
Net exercise of stock options (in shares)   49,000      
Net exercise of stock options 294   294    
Dividends [1] (1,010)     (1,010)  
Ending Balance (in shares) at Jun. 30, 2026   22,989,000      
Balance at end of year at Jun. 30, 2026 $ 217,477 $ 230 $ 285,571 $ (50,533) $ (17,791)
[1] Cash dividends declared per share of common stock were $0.085 and $0.085 in the six months ended June 30, 2026 and 2025, respectively.